Abstract
Ca2+ disturbances are observed when Ca2+-dependent cysteine proteases malfunction, causing muscle weakness and wasting. For example, loss of calpain-3 (CAPN3) activity leads to limb-girdle muscular dystrophy 2A (LGMD2A). In neuronal excitotoxicity, the cleavage of the Na+-Ca2+ exchanger isoform 3 (NCX3) has been associated with an increase in activity and elevation of the Ca2+ content in the endoplasmic reticulum (ER). Since NCX3 is expressed in skeletal muscle, we evaluated the cleavage of different NCX3 splice variants by CAPN1 and CAPN3. Using Fura-2-based cellular Ca2+ imaging, we showed for the first time that CAPN3 increases NCX3 activity and that only NCX3-AC, the variant predominantly expressed in skeletal muscle, is sensitive to calpain. The silencing of the endogenous CAPN1 and the expression of the inactive form of CAPN3 (C129S CAPN3) confirmed the specificity for CAPN1 and CAPN3. Functional studies revealed that cellular Ca2+ uptake through the reverse mode of NCX3 was significantly increased independently of the mode of activation of the exchanger by either a rise in intracellular Ca2+ ([Ca2+]i) or Na+ ([Na+]i). Subsequently, the sensitivity to CAPN1 and CAPN3 could be abrogated by removal of the six residues coded in exon C of NCX3-AC. Additionally, mutation of the Leu-600 and Leu-601 suggested the presence of a cleavage site at Leu-602. The increased Ca2+ uptake of NCX3 might participate in the Ca2+ refilling of the sarcoplasmic reticulum (SR) after the excitation-contraction uncoupling following exercise and therefore be implicated in the impaired reticular Ca2+ storage observed in LGMD2A.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The calpain proteases are Ca2+-dependent cysteine proteases expressed throughout the entire body. A compromised function of one of the calpain family members can lead to diverse pathologies such as embryonic lethality, gastropathy, muscular dystrophy, or platelet dysfunction [13]. In the human genome, 15 members of the calpain family have been found (CAPN1 to CAPN15) [47]. The distinctive characteristic of calpain lies in its activation by a rise in intracellular Ca2+ levels ([Ca2+]i). This phenomenon triggers the autolysis of the protease. The cytosolic concentration of Ca2+ required for this activation differs between isoforms. The targets of its proteolysis are difficult to predict as the calpain family recognizes a tertiary structure and not the primary sequence unlike many conventional proteases [29].
Contrary to CAPN1 and CAPN2 that are ubiquitously expressed, the third isoform CAPN3 is restricted to the skeletal muscle. Interestingly, nanomolar levels of Ca2+ are sufficient to activate CAPN3 while CAPN1 and CAPN2 require micromolar and millimolar concentrations, respectively [5]. In physiological conditions, CAPN3 is activated when local Ca2+ levels are higher than 200 nM over a long period. Such requirements are met following eccentric contractions [32, 33]. However, in tetanic and concentric contractions, CAPN3 remains in its inactive state, which makes CAPN3 activity specific to certain types of contractions.
CAPN3 dysfunction causes the limb-girdle muscular dystrophy (LGMD) 2A also called calpainopathy, which is the most common type of LGMD, with 30 % of the patients [39]. The LGMD2A is an autosomal recessive form of muscular dystrophy characterized by muscle weakness of the proximal limb-girdle muscles eventually leading to a loss of ambulation. It derives from a single mutation of CAPN3 causing a defect in CAPN3 function. As of now, 97 distinct mutations have been identified as a cause of LGMD2A [40].
Among many peculiarities, CAPN3 is not freely present in the cytoplasm like CAPN1 and CAPN2 but tightly bound to the N2 region of the myofiber [22] and to the triad [23] formed by a central t-tubule and two terminal cisternae of the sarcoplasmic reticulum (SR). In this region where many Ca2+ transporters are present, a tight control of the Ca2+ fluxes is maintained during excitation-contraction coupling by connecting the SR to the sarcolemma [1]. The absence of CAPN3 or its impaired function is linked with Ca2+ disturbances within the myofibers including a decrease in Ca2+ release from the SR [23]. Such impairments could well contribute to the clinical phenotype of the LGMD2A. Therefore, the investigation of the role of CAPN3 on the Ca2+ fluxes occurring at the triad is of great interest.
Recently, the Na+-Ca2+ exchanger family (NCX) has been shown to be a substrate of CAPN1 and CAPN2 [4]. The third member of the family, NCX3, was revealed to be the only isoform specifically cleaved during excitotoxic conditions [4]. NCX cleavage modifies its activity and the resulting Ca2+ influx [37]. Interestingly, NCX3 is also expressed in the skeletal muscles and has been found at the triad [41] where it extrudes Ca2+ across the sarcolemma prior to relaxation. Recently, NCX3 was hypothesized to be involved in the regulation of Ca2+ beyond Ca2+ extrusion, and several studies have suggested a role for NCX3 in Ca2+ re-entry into the SR [11, 30] during prolonged exercise.
The expression of NCX3 can give rise to different variants [38] due to an alternative splicing. Two variants have been described in mice NCX3-AC and NCX3-B. Previous work from our group showed that these variants have different capacities of exchange in physiological situations [30]. It is however unclear whether the calpain family cleaves both variants and how the cleavage affects their functional properties.
In the present study, we investigated for the first time the sensitivity of the different NCX3 variants to calpain using Fura-2-based Ca2+ imaging in presence of the calpain inhibitor calpastatin. The results were confirmed by the use of a siRNA targeting specifically CAPN1. By expressing both CAPN3 and its inactive form (C129S CAPN3), a novel regulation of NCX3 variants by the skeletal muscle CAPN3 was found. These properties were further compared with the expression pattern of the two variants among the different myofiber types. Finally, the combination of data concerning the reverse mode triggered by [Ca2+]i and by [Na+]i, together with the use of site-directed mutagenesis, enabled a full characterization of the transport capacities of the exchanger upon regulation by calpain and provided a new insight into the molecular determinants responsible for this sensitivity.
Experimental procedures
Animal model
Four C57BL/6 mice were sacrificed, and subsequently, the skeletal muscles from the left and right hind limbs were dissected and directly frozen in liquid nitrogen in order to obtain the gastrocnemius (Gast), the tibialis anterior (TA), the extensor digitorum longus (EDL), and the soleus. The heart sample used as a negative control was removed from four C57BL/6 mice.
Cell lines and transfection
The human embryonic kidney cells HEK293T were cultured in a Dulbecco’s modified Eagle’s medium (Bio Whittaker-Europe, Verviers, Belgium) containing 10 % (v/v) fetal calf serum and 2 mM l-glutamine at 37 °C with 5 % (v/v) CO2. Forty-eight hours prior to experiments, cells were seeded on a six-well plate and transiently transfected. For double transfections, cells received 1 μg of the each constructs for a total of 2 μg/well, using polyethylenimine cationic polymer PEI (Polysciences Inc., Warrington, PA) in accordance with the manufacturer’s instructions.
Cloning and mutagenesis
Coding sequence of the human calpastatin (hCAST) was obtained from Dharmacon Research Inc. (Lafayette, CO). Human calpain-3 (hCAPN3) (kindly provided by Dr. van der Maarel, Leiden, The Netherlands) was subcloned into a pCINeo IRES-mCherry backbone. The subcloning of the mice NCX3-AC and NCX3-B into pCINeo IRES-GFP vectors with a HA-Tag fused at the N-terminus of the protein has been previously described in detail [30]. Calpain cleavage sites were predicted using the group base prediction system-calpain cleavage detector (GPS-CCD) 1.0 prediction tool [27]. The variant-specific cleavage site was mutated using site-directed mutagenesis, performed on NCX3-AC leading to the following mutation: LL-600601-WW NCX3-AC targeting the cleavage sites. Additionally, the exon C consisting of the ALLLSP region could be removed to NCX3-AC (NCX3-A) and the C129S mutation inserted in hCAPN3 using a Quick-change site-directed mutagenesis kit (Stratagene, La Jolla, CA).
Expression profile and quantitative real-time polymerase chain reaction analysis
Tissue RNA was extracted using TRIzol total RNA Isolation Reagent (Life Technologies BRL, Breda, The Netherlands). After DNAse treatment (Promega, Madison, WI), 1.5 μg of RNA was reverse-transcribed by Moloney-Murine Leukemia Virus-Reverse Transcriptase (Invitrogen, Carlsbad, CA) as previously described [15]. Using a CFX96 real-time PCR detection system (Bio-Rad, Hercules, CA), the relative quantification of NCX3 and the calpain isoforms were measured in the cDNA from tissues and normalized according to the Livak method on GAPDH expression. Absolute quantification of the variants NCX3-AC and NCX3-B was calculated thanks to NCX3 standard curves generated by using a diluted pCINeo-IRES-eGFP-mNCX3-AC and pCINeo-IRES-eGFP-mNCX3-B vectors. Calculations were performed as previously described [30, 51] in order to obtain the absolute copy number for each variant. Sequences were amplified using the validated primers described in the table below (Table 1).
Silencing of calpain-1
Downregulation of CAPN1 expression was performed using siRNA targeting human calpain-1 and consisting of three to five target-specific 19–25 nt siRNAs (Santacruz, Dallas, TX) and a control siRNA (Dharmacon Research Inc., Lafayette, CO). Twenty-four hours after plating, HEK293T cells were transfected with an optimized concentration of 30 nM of siRNA and 1 μg/well of the NCX3 construct, NCX3-AC or NCX3-B, and 1 μg/well of mock vector using Lipofectamine. Functional experiments were performed 72 h after transfection, time required for an optimal downregulation with such siRNA.
Immunoblot analysis
HEK293T cells were lysed at 4 °C in a solution of 150 mM NaCl, 5 mM EGTA, 50 mM Tris, pH adjusted to 7.5 with NaOH, Triton X-100 0.5 % (v/v), and protease inhibitors (1 mM PMSF, 5 μg/mL leupeptin, 1 μg/mL aprotinin, 1 μg/mL pepstatin). After centrifugation at 12,000×g for 10 min, 5× Laemmli buffer containing 100 nM dithiothreitol was added to the supernatant. Lysates were subjected to SDS–PAGE 8 % (w/v) and electroblotted onto polyvinylidene difluoride (PVDF) membranes. Blots were incubated with 5 % (w/v) non-fat dried milk in TBS-T (137 mM NaCl, 0.2 % (v/v), Tween-20, and 20 mM Tris/HCl, pH 7.6). Immunoblots were incubated overnight at 4 °C with either a mouse anti-beta-actin antibody (1:1,000) (Sigma, MO, USA) or a goat anti-calpain-1 (1:150) (Santacruz, Dallas, TX) diluted in 1 % (w/v) milk in TBS-T. PVDF membranes were incubated 1 h at room temperature with a sheep horseradish peroxidase-conjugated anti-goat (1:2,000) or anti-mouse (1:10,000) antibody (Sigma, MO, USA) in TBS-T. Afterwards, blots were visualized using the enhanced chemiluminescence system (ECL, Thermo Fisher).
Fura-2 measurements
NCX3 activity was measured by recording intracellular Ca2+ level. HEK293T cells were seeded on coverslips coated with fibronectin (Roche, Mannheim, Germany) prior to transfection. Forty-eight hours after transfection, the cells were loaded for 20 min at 37 °C with the ratiometric probe Fura-2-AM 3 μM and 0.01 % (v/v) pluronic acid F-127 (Invitrogen, Carlsbad, CA) in Krebs solution (5.5 mM KCl, 147 mM NaCl, 1.2 mM MgCl2, 1.5 mM CaCl2, 10 mM glucose, and 10 mM HEPES/NaOH, pH 7.4). After a 10-min wash, coverslips were mounted onto a stage of an inverted microscope (Zeiss Axiovert 200M, Carl Zeiss, Jena, Germany). Changes in medium and addition of compounds were facilitated using a perfusion system. [Ca2+]i was monitored by exciting Fura-2 with monochromatic light of wavelength 340 and 380 nm (Polychrome IV, TILL Photonics, Gräfelfing, Germany). Fluorescence emission was directed by a 415DCLP dichroic mirror (Omega Optical, Inc., Brattleboro, VT) through a 510WB40 emission filter (Omega Optical, Inc.) onto a CoolSNAP HQ monochrome charge-coupled device (CCD) camera (Roper Scientific, Vianen, The Netherlands). The integration time of the CCD camera was set at 200 ms with a sampling interval of 3 s. All hardware was controlled with Metafluor software (version 6.0, Universal Imaging Corp., Downingtown, PA). For each wavelength, the mean fluorescence intensity was monitored in an intracellular region and, for purpose of background correction, in an extracellular region of identical size. After background correction, the fluorescence emission ratio (340 nm/380 nm) was calculated to determine the Fura-2 ratios. Ten to 19 individual GFP-positive cells were selected and monitored simultaneously from each coverslip. After double transfection of CAPN3 and NCX3, only cells positive for both GFP and mCherry were selected. The reverse mode of NCX activity was evaluated using the Ca2+ uptake that follows the removal of extracellular Na+ using a NMDG solution (5.5 mM KCl, 147 mM N-methyl glucamine, 1.2 mM MgCl2, 1.5 mM CaCl2, 10 mM glucose, and 10 mM HEPES/HCl, pH 7.4) [43]. All buffers were kept at 37 °C and the variability in osmolality was lower than 5 mOsm. The activation of the reverse mode of the exchanger was achieved by either raising the [Ca2+]i using the sarcoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (1 μM) simultaneously with the Na+ removal or raising the [Na+]i with a 60-min incubation in presence of the inhibitor of the Na+-K+ ATPase ouabain (1 μM) [43] prior to the experiments with a perfusion during recordings.
Statistical analysis
All results are based on at least three different sessions of experiments. The Fura-2 ratio is an average of ≥50 individual cells. Values are expressed as means ± SEM. Statistical significance (P < 0.05) was determined using one-way ANOVA with the Bonferroni’s procedure.
Results
Expression of calpains and NCX3 in skeletal muscle
Using RT-PCR, mRNA levels of the calpain family members were measured in cardiac tissues and skeletal muscles of different fiber types: slow-twitch fibers predominant in the soleus, fast-twitch fibers dominant in the extensor digitorum longus (EDL), or mixed fibers such as those found in the gastrocnemius and the tibialis anterior (TA). The measurements revealed that calpains were highly expressed in soleus, showing 2.3-, 2.9-, and 3.3-fold increases for CAPN1, CAPN2, and CAPN3, respectively, compared to the other skeletal muscles (Fig. 1a–c). Expression of CAPN1 in the heart was somewhat lower with a 1.3 fold-increase expression compared to the gastrocnemius, while CAPN2 was increased by a factor of 4.1. Finally, CAPN3 expression in cardiac tissue was more than 55 times lower than in skeletal muscle. A similar expression pattern was observed for NCX3, which confirmed the specific enrichment of both CAPN3 and NCX3 in the skeletal muscle (Fig. 1d). NCX3 expression was highest in the EDL, followed by the soleus, the TA, and the gastrocnemius. Using an absolute quantification method, we were able to obtain the percentage of the different variants of NCX3, NCX3-AC containing both exons A and C, and NCX-B containing only the exon B (Fig. 1e). These data revealed the predominance of NCX3-AC in all fiber types. However, in the soleus, NCX3-AC was 72 % of the total NCX3, while for the other fiber type, this percentage was higher than 94 %.
Effect of CAPN on NCX3 activity
The effect of calpain activation on NCX3 reverse activity was investigated using the ratiometric Fura-2 probe. The reverse mode of exchange, where Ca2+ enters the cell, was triggered by the switch to a Na+-free medium together with a rise in either [Na+]i or [Ca2+]i. In order to elevate the Ca2+ levels, the cells were perfused with a Na+-free medium containing thapsigargin. Thapsigargin inhibits the SERCA ATPase and therefore prevents the re-uptake of Ca2+ in the endoplasmic reticulum (ER). As the ER constitutively leaks Ca2+, the Ca2+ stocks were emptied in a slow manner. [Na+]i was elevated by incubating cells with ouabain in a Na+-rich medium prior to the measurements. By blocking the Na+-K+-ATPase, ouabain causes a gradual rise in intracellular Na+ until similar concentrations across the plasma membrane are reached. The activity of both variants of NCX3 was recorded in HEK293T cells expressing an NCX3 variant together with an empty vector (Mock) or the calpain inhibitor calpastatin (CAST). Importantly, our group previously determined the plasma membrane localization of NCX3 in transfected HEK293T cells by cell surface biotinylation. Importantly, NCX3-AC and NCX3-B were both expressed at the plasma membrane in similar amount [30].
In NCX3-B expressing cells, exchange activity remained unchanged by the expression of calpastatin, while the exchange capacity of NCX3-AC was decreased (Fig. 2a, c). Thus, in the reverse mode, the calpastatin expression caused a significant decrease in the maximum Ca2+ levels measured in the NCX3-AC expressing cells under Na+-free conditions (Fig. 2b, e), regardless of whether intracellular Ca2+ or Na+ was increased. Furthermore, the expression of the calpain inhibitor significantly diminished the initial Ca2+ uptake observed in NCX3-AC expressing cells in the presence of extracellular Na+ and ouabain (Fig. 2d).
Silencing of CAPN1 and the NCX3 Ca2+ uptake
CAPN1, CAPN2, and CAPN3 are the three major isoforms of calpains found in skeletal muscle. CAPN1 and CAPN2 are also ubiquitously expressed and therefore endogenously expressed in HEK293T. Due to their different thresholds of activation by Ca2+, CAPN1 was more likely to be the unique isoform activated during our functional assays as its threshold is in the micromolar range, and CAPN2 is activated by Ca2+ fluxes in the millimolar range. Incubating the cells with thapsigargin resulted in a mild rise of [Ca2+]i in the micromolar range. In a similar manner, the incubation of cells expressing NCX3 with ouabain gradually raised Na+ levels and triggered a Ca2+ influx that was able to activate CAPN1 [12]. In order to investigate the potential role of CAPN1 on the activity of NCX3 variants, CAPN1 was silenced using siRNA specifically targeting CAPN1 in HEK293T. The expression of CAPN1 was measured by immunoblotting 72 h after transfection (Fig. 3e). CAPN1 has an electrophoretic mobility of 80 kDa [52]. The quantification revealed a significant downregulation of 50 %. As with the cells transfected with calpastatin, the direct silencing of CAPN1 had no effect on NCX3-B activity in reverse mode activated by either [Na+]i or [Ca2+]i (Fig. 3a, d). Nonetheless, in the reverse mode conditions triggered by intracellular Ca2+, silencing CAPN1 significantly decreased the maximum Ca2+ uptake of the NCX3-AC expressing cells compared to the untargeted siRNA conditions (Fig. 3b). This effect is also observed when [Na+]i is increased, where intracellular Ca2+ uptake is significantly decreased during perfusion with a Na+-rich medium (Fig. 3d).
Influence of the proteolytic activity of CAPN3 on NCX3 capacity
The third isoform of calpain, CAPN3, was not expressed in our cell model and was therefore transfected together with NCX3 variants. The overexpression resulted in an increase in the maximum intracellular Ca2+ levels recorded in NCX3-AC expressing cells in both thapsigargin and ouabain conditions (Fig. 4). Additionally, the baseline measured after ouabain incubation was significantly elevated compared to the normal conditions revealing a higher Ca2+ uptake in presence of extracellular Na+ (Fig. 4d). In both conditions, the exchange capacity of the NCX3-B expressing cells remained unchanged.
Site-directed mutagenesis was used to introduce a C129S mutation in the CAPN3 sequence. This mutation inactivated the catalytic site of CAPN3 [14]. In cells expressing C129S CAPN3, the function of NCX3-B measured in both ouabain and thapsigargin conditions was unchanged, while the increase in Ca2+ uptake observed for NCX3-AC was abrogated (Fig. 4b, d, and e).
Targeting the molecular determinants of the regulation by calpain
The data recorded in Figs. 2, 3, and 4 clearly demonstrated that NCX3-AC activity is regulated by different calpains. Additionally, one of the cleavage sites for calpain predicted by the software program GPS-CCD 1.0 [27] is located in the exon C of NCX3-AC, between the Leu-601 and Leu-602 (Fig. 5a). Next, exon C was removed by site-directed mutagenesis. The mutant NCX3-A had a significantly lower Ca2+ uptake when incubated with thapsigargin than NCX3-AC (Fig. 5b, c). This decrease corresponded to the observed effect of silencing of CAPN1 and remained significantly higher than NCX3-B activity. Furthermore, expression of CAST or CAPN3 had no significant effect on the Ca2+ uptake recorded for NCX3-A expressing cells (Fig. 5b, c), which confirms that the exon C is directly implicated in the regulation by calpain possibly by cleavage.
The positions −1 and −2 of a cleavage site are of major importance for the recognition of the site by calpain [49]. Therefore, the residues Leu-600 and Leu-601 were mutated into Trp-600 and Trp-601, residues carrying the lowest probability of occurrence in a calpain cleavage site [49], and unlikely to be recognized by the calpain. In the reverse mode activated by an increase in [Ca2+]i, the capacity of the LL600601WW-NCX3-AC mutant was significantly decreased compared to NCX3-AC and similar to NCX3-A (Fig. 5b, c). In a similar manner, during reverse activation by an increase in [Na+]i, the highest intracellular Ca2+ value of LL600601WW-NCX3-AC in Na+-free conditions is decreased compared to NCX3-AC expressing cells (Fig. 5d, f). In Na+-rich conditions, the exchange capacity of LL600601WW-NCX3-AC mutant as observed by the baseline of Fura-2 during ouabain exposure was decreased compared to NCX3-AC (Fig. 5e), but it was identical to NCX3-AC in the presence of calpastatin while remaining significantly higher than NCX3-B. The LL600601WW-NCX3-AC activity remained unchanged in CAST and CAPN3 conditions in both thapsigargin and ouabain conditions, similarly to NCX3-A. Thereby, the mutation of the two residues abrogated the regulation of the exchanger by both CAPN1 and CAPN3.
Discussion
The present study unraveled for the first time the influence of the muscle-specific CAPN3 on the activity of NCX3. Furthermore, this study revealed the specificity of CAPN1 and CAPN3 for the variant NCX3-AC, predominant in skeletal muscle, as an increase of the reverse mode of exchange is observed solely for this variant and implicates the presence of the exon C to be responsible for the CAPN effect. First, the muscle-specific CAPN3 elevated the Ca2+ uptake performed by NCX3-AC in its reverse mode triggered by a rise in either [Ca2+]i or [Na+]i. Such an increase was absent in NCX3-B expressing cells. The involvement of CAPN3 catalytic activity was further demonstrated by the lack of effect with the inactive form of CAPN3, the C129S mutant. Secondly, the inhibition by calpastatin of multiple proteases such as CAPN1 and CAPN2 decreased Ca2+ uptake by NCX3-AC, an effect unique to this variant. The silencing of CAPN1 confirmed this effect, thereby suggesting that CAPN2 and additional intracellular proteases inhibited by calpastatin have no influence on NCX3 activity [2]. Together, these results help to unravel the roles of CAPN1 and CAPN3 in increasing the reverse mode capacity of NCX3.
In the present experiments, the NCX3 activity was triggered by a Na+ removal in the extracellular medium, which lead to a strong intracellular Ca2+ entry. Such entry provokes CAPN1 autolysis as this process can be rapidly achieved following a strong Ca2+ rise, although in diverse cell types, CAPN1 can also be found in its autolyzed form at resting state [6, 35]. In this regard, previous study from our group has shown that Ca2+ levels in HEK293T cells expressing NCX3-AC and NCX3-B were unchanged in both cytoplasm and ER at resting state [30]. Therefore, CAPN1 activation in this study is expected to be similar in all conditions.
Additionally, this study identified the molecular determinants of the calpain sensitivity. Among the predicted sites for calpain cleavage, a variant-specific site was predicted in exon C, and the activity of NCX3-A, a mutant missing the exon C, was measured. NCX3-A had an activity similar to the one recorded under CAPN1 inhibition by either calpastatin or siRNA, thereby demonstrating the loss of the calpain sensitivity. The two key residues of the hypothesized calpain cleavage site, Leu-600 and Leu-601, were mutated into Trp-600 and Trp-601, respectively. These mutations diminished the Ca2+ uptake performed in the reverse mode of exchange by NCX3-AC. The similarity to NCX3-A activity confirmed the implication of the two residues Leu-600 and Leu-601 in the regulation of NCX3-AC by calpain, which possibly occurs by cleavage. However, the decreased activity of NCX3-AC in the absence of calpain cannot fully explain the differences observed between the variant NCX3-AC and NCX3-B, as the mutations of Leu-600 and Leu-601 are not sufficient to obtain the properties of NCX3-B. The difference between the two variants has been previously attributed to the mutually exclusive exons A and B and their influence on the Ca2+-binding domain 2 (CBD2) of the intracellular loop of NCX3. However, the exon C, responsible for the sensitivity to calpain, most likely contributes as well to the functional differences between the two variants. This additional effect of exon C could explain the inability of any of the mutations targeting the CBD2 in exon B of NCX3-B to fully reproduce NCX3-AC activity in the reverse mode activated by intracellular Na+ [30].
Calpain recognizes its cleavage site by the primary sequence as well as the tertiary structure, which complicates the identification of a consensus sequence for the calpain cleavage site. Tompa et al. attempted to pinpoint the residues necessary for cleavage in 11 amino acids [49]. The exon C, where a calpain cleavage site is predicted at Leu-602, carries only six residues—ALLLSP—that have a high occurrence in calpain cleavage sites [49]. Here, the investigation of the potential cleavage of NCX3-AC at Leu-602 and detection of its generated fragments would be needed to confirm whether or not the exon C is carrying a cleavage site for calpain. Furthermore, the neighboring sequence at the end of exon A and at the beginning of exon 5 is of importance as well for the recognition by calpain. The point mutation of each residue of this region would provide further information on which residues are necessary for the recognition by calpain.
Interestingly, the three Leucine residues located next to the predicted cleavage site are conserved within the NCX family. NCX2, expressed in the brain, also expresses the exon C of sequence –ALLLNQ-. In NCX1, the exon C of sequence –ALLLNEL- [38] is alternatively spliced. The splice variants of NCX1 carrying the exon C are detected in excitable tissues [24, 28, 38]. Additionally, the cleavage of NCX by the calpain family has only been reported in excitable tissues [3, 4, 50]. Therefore, the implication of the exon C in the regulation of both NCX1 and NCX2 and its potential cleavage by calpain at position Leu-602 warrants further exploration.
The cleavage of NCX3 by CAPN1, leading to a hyperactive exchanger, has been reported previously [37]. The description by Bano et al. of the cleavage sites in neurons did not describe a site located on the exon C [4]. Furthermore, NCX3-B is predominant in neuronal tissues, but in our experiments, NCX3-B was unaffected by CAPN1. This could be explained by the different cellular model used and conditions of experiments that would lead to diverse status of the cells. It has been found that several types of post-translational regulation, such as calmodulin binding [18, 46], phosphorylation [34, 53], and phosphoinositide binding [48], can be involved in protecting the cleavage site of the target protein or favor a specific site of cleavage. From these different studies, some common mechanisms arise. First, the intracellular loop of NCX3 is of significant importance for NCX3 regulation. Secondly, in NCX3 as well as in diverse Ca2+ channels [21, 42] and transporters [19, 44], the proteolytic activity of the calpain family goes beyond its role in protein degradation and provides an additional Ca2+-dependent regulatory mechanism in order to adjust the Ca2+ fluxes of the cells.
In this study, we have shown that CAPN1, CAPN2, and the muscle-specific CAPN3 are expressed in skeletal muscle. Unlike CAPN2, CAPN1 and CAPN3 can be activated under physiological conditions in myofibers. CAPN1, freely present in the sarcoplasm, is autolyzed and activated during the prolonged elevation of [Ca2+]i to micromolar levels such as that following eccentric exercise. In these conditions, a disruption of the excitation-contraction (EC) coupling can occur, caused by the decrease in Ca2+ release from the SR that could lead to post-exercise fatigue and contribute to the muscle weakness observed in several muscular pathologies [25]. In the myocardium, the CAPN1 activation observed during an ischemic event affects the SR Ca2+ content and release capacity leading to a cardiac contractile dysfunction [45]. Therefore, the increased activity of NCX3-AC caused by CAPN1 could either constitute a protective attempt to refill the intracellular Ca2+ stores in skeletal muscle and to delay the E-C uncoupling or to compete with the Ca2+ re-uptake into the SR by an enhanced Ca2+ extrusion. The low rate of [Ca2+]i increase during these specific uncoupling events greatly favors the activation of the reverse mode. Furthermore, the capacity of NCX to refill the SR Ca2+ levels has been observed in several excitable tissues such as cardiomyocytes [16], slow-twitch fibers [11], and smooth muscle cells [8, 26]. Additionally, both an elevated CAPN1 activity [54] and an increased capacity of exchange by NCX [10] were observed in the mdx model of Duchenne muscular dystrophy, where higher sarcoplasmic Ca2+ levels were found. Finally, the cleavage of NCX3 by calpain in neurons provoked a significant increase in ER Ca2+ content and delayed the caspase activation during neuronal excitotoxicity [37].
Regarding CAPN3, in the myofiber, the protease is tightly bound at the myofibril, and at the triad, a privileged region for Ca2+ fluxes responsible for the EC coupling. The conditions necessary for CAPN3 activation are not yet fully understood. Its activation seems to occur from 24 to 48 h following eccentric exercise [31], a phase of intense sarcomeric remodeling where the SR Ca2+ content slowly rises again until it reaches normal levels 48 h after exercise [7]. The increase in NCX3 activity following CAPN3 cleavage could, therefore, be involved in the persistent increase in the Ca2+ content of the SR during the days following eccentric exercise. This hypothesis is consistent with the Ca2+ disturbances [9, 23], such as a low Ca2+ release from the SR, observed in the CAPN3 knock-out (KO) fibers mimicking the LGMD2A condition. Additionally, while several potential substrates of CAPN3 appear to be affected by the protease through non-proteolytic action [36], the proteolytically inactive CAPN3 (C129S CAPN3) was not shown to have any effect on NCX3-AC activity, further demonstrating that CAPN3 modulates NCX3-AC through cleavage. It has to be noted that in our study, the CAPN3 is expressed in high levels and freely present in the cytoplasm of the HEK cells, therefore more prone to activation at lower [Ca2+]i. This might well explain the activation of CAPN3 in our experiments despite the specific requirements for its activation, described by others, in terms of [Ca2+]i and exercise. Our study has been performed in HEK cells, as a well-used cell model for the investigation of the capacity of exchange and the ionic regulations of the NCX family [17, 20]. The study of the regulation of NCX3 by calpain in the dense cellular organization of the myofiber would be essential in order to conclude on the role of NCX3 in the Ca2+ disturbances of LGMD2A.
In conclusion, a novel target sensitive to the muscle-specific CAPN3 was identified. This sensitivity was found to be restricted to the skeletal muscle variant NCX3-AC. The site located in the exon C was identified as implicated in the regulation of the exchanger by CAPN1 and CAPN3, possibly by a direct cleavage and might be involved with other Ca2+ transporters in the Ca2+ refilling of the SR, subsequent to the EC uncoupling. The loss of regulation of NCX3 by CAPN3 could therefore be implicated in diverse muscular pathologies such as the LGMD2A.
References
Al-Qusairi L, Laporte J (2011) T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases. Skelet Muscle 1:26. doi:10.1186/2044-5040-1-26
Ali MA, Stepanko A, Fan X, Holt A, Schulz R (2012) Calpain inhibitors exhibit matrix metalloproteinase-2 inhibitory activity. Biochem Biophys Res Commun 423:1–5. doi:10.1016/j.bbrc.2012.05.005
Atherton J, Kurbatskaya K, Bondulich M, Croft CL, Garwood CJ, Chhabra R, Wray S, Jeromin A, Hanger DP, Noble W (2014) Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Abeta in Alzheimer's disease. Aging Cell 13:49–59. doi:10.1111/acel.12148
Bano D, Young KW, Guerin CJ, Lefeuvre R, Rothwell NJ, Naldini L, Rizzuto R, Carafoli E, Nicotera P (2005) Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell 120:275–285. doi:10.1016/j.cell.2004.11.049
Branca D, Gugliucci A, Bano D, Brini M, Carafoli E (1999) Expression, partial purification and functional properties of the muscle-specific calpain isoform p94. Eur J Biochem 265:839–846
Campbell JS, Hallett MB (2015) Active calpain in phagocytically competent human neutrophils: electroinjection of fluorogenic calpain substrate. Biochem Biophys Res Commun 457:341–346. doi:10.1016/j.bbrc.2014.12.113
Chen W, Ruell PA, Ghoddusi M, Kee A, Hardeman EC, Hoffman KM, Thompson MW (2007) Ultrastructural changes and sarcoplasmic reticulum Ca2+ regulation in red vastus muscle following eccentric exercise in the rat. Exp Physiol 92:437–447. doi:10.1113/expphysiol.2006.036442
Davis KA, Samson SE, Hammel KE, Kiss L, Fulop F, Grover AK (2009) Functional linkage of Na+-Ca2+-exchanger to sarco/endoplasmic reticulum Ca2+ pump in coronary artery: comparison of smooth muscle and endothelial cells. J Cell Mol Med 13:1775–1783. doi:10.1111/j.1582-4934.2008.00480.x
Dayanithi G, Richard I, Viero C, Mazuc E, Mallie S, Valmier J, Bourg N, Herasse M, Marty I, Lefranc G, Mangeat P, Baghdiguian S (2009) Alteration of sarcoplasmic reticulum ca release in skeletal muscle from calpain 3-deficient mice. Int J Cell Biol 2009:340346. doi:10.1155/2009/340346
Deval E, Levitsky DO, Marchand E, Cantereau A, Raymond G, Cognard C (2002) Na(+)/Ca(2+) exchange in human myotubes: intracellular calcium rises in response to external sodium depletion are enhanced in DMD. Neuromuscul Disord 12:665–673
Germinario E, Esposito A, Midrio M, Peron S, Palade PT, Betto R, Danieli-Betto D (2008) High-frequency fatigue of skeletal muscle: role of extracellular Ca(2+). Eur J Appl Physiol 104:445–453. doi:10.1007/s00421-008-0796-5
Harwood SM, Allen DA, Chesser AM, New DI, Raftery MJ, Yaqoob MM (2003) Calpain is activated in experimental uremia: is calpain a mediator of uremia-induced myocardial injury? Kidney Int 63:866–877. doi:10.1046/j.1523-1755.2003.00823.x
Hata S, Abe M, Suzuki H, Kitamura F, Toyama-Sorimachi N, Abe K, Sakimura K, Sorimachi H (2010) Calpain 8/nCL-2 and calpain 9/nCL-4 constitute an active protease complex, G-calpain, involved in gastric mucosal defense. PLoS Genet 6, e1001040. doi:10.1371/journal.pgen.1001040
Herasse M, Ono Y, Fougerousse F, Kimura E, Stockholm D, Beley C, Montarras D, Pinset C, Sorimachi H, Suzuki K, Beckmann JS, Richard I (1999) Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol Cell Biol 19:4047–4055
Hoenderop JG, Hartog A, Stuiver M, Doucet A, Willems PH, Bindels RJ (2000) Localization of the epithelial Ca(2+) channel in rabbit kidney and intestine. J Am Soc Nephrol 11:1171–1178
Hove-Madsen L, Tort L (2001) Characterization of the relationship between Na+-Ca2+ exchange rate and cytosolic calcium in trout cardiac myocytes. Pflugers Arch 441:701–708
Hurtado C, Prociuk M, Maddaford TG, Dibrov E, Mesaeli N, Hryshko LV, Pierce GN (2006) Cells expressing unique Na+/Ca2+ exchange (NCX1) splice variants exhibit different susceptibilities to Ca2+ overload. Am J Physiol Heart Circ Physiol 290:H2155–H2162. doi:10.1152/ajpheart.00958.2005
Iwamoto N, Lu R, Tanaka N, Abe-Dohmae S, Yokoyama S (2010) Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates high-density lipoprotein generation. Arterioscler Thromb Vasc Biol 30:1446–1452. doi:10.1161/ATVBAHA.110.203927
James P, Vorherr T, Krebs J, Morelli A, Castello G, McCormick DJ, Penniston JT, De Flora A, Carafoli E (1989) Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J Biol Chem 264:8289–8296
John SA, Ribalet B, Weiss JN, Philipson KD, Ottolia M (2011) Ca2+-dependent structural rearrangements within Na+-Ca2+ exchanger dimers. Proc Natl Acad Sci U S A 108:1699–1704. doi:10.1073/pnas.1016114108
Kaczmarek JS, Riccio A, Clapham DE (2012) Calpain cleaves and activates the TRPC5 channel to participate in semaphorin 3A-induced neuronal growth cone collapse. Proc Natl Acad Sci U S A 109:7888–7892. doi:10.1073/pnas.1205869109
Keira Y, Noguchi S, Minami N, Hayashi YK, Nishino I (2003) Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle. J Biochem 133:659–664
Kramerova I, Kudryashova E, Wu B, Ottenheijm C, Granzier H, Spencer MJ (2008) Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle. Hum Mol Genet 17:3271–3280. doi:10.1093/hmg/ddn223
Kuroda H, Sobhan U, Sato M, Tsumura M, Ichinohe T, Tazaki M, Shibukawa Y (2013) Sodium-calcium exchangers in rat trigeminal ganglion neurons. Mol Pain 9:22. doi:10.1186/1744-8069-9-22
Lamb GD (2009) Mechanisms of excitation-contraction uncoupling relevant to activity-induced muscle fatigue. Appl Physiol Nutr Metab 34:368–372. doi:10.1139/H09-032
Lemos VS, Poburko D, Liao CH, Cole WC, van Breemen C (2007) Na+ entry via TRPC6 causes Ca2+ entry via NCX reversal in ATP stimulated smooth muscle cells. Biochem Biophys Res Commun 352:130–134. doi:10.1016/j.bbrc.2006.10.160
Liu Z, Cao J, Gao X, Ma Q, Ren J, Xue Y (2011) GPS-CCD: a novel computational program for the prediction of calpain cleavage sites. PLoS One 6, e19001. doi:10.1371/journal.pone.0019001
Long Y, Wang WP, Yuan H, Ma SP, Feng N, Wang L, Wang XL (2013) Functional comparison of the reverse mode of Na+/Ca2+ exchangers NCX1.1 and NCX1.5 expressed in CHO cells. Acta Pharmacol Sin 34:691–698. doi:10.1038/aps.2013.4
McDermott JR, Mantle D, Biggins JA, Kidd AM, Davison K, Lauffart B, Pennington RJ (1985) Specificity of neuropeptide degradation by two calcium-activated neutral proteases from human skeletal muscle. Life Sci 37:725–730
Michel LY, Verkaart S, Koopman WJ, Willems PH, Hoenderop JG, Bindels RJ (2014) Function and regulation of the Na+-Ca2+ exchanger NCX3 splice variants in brain and skeletal muscle. J Biol Chem 289:11293–11303. doi:10.1074/jbc.M113.529388
Murphy RM, Goodman CA, McKenna MJ, Bennie J, Leikis M, Lamb GD (2007) Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise. J Appl Physiol (1985) 103:926–931. doi:10.1152/japplphysiol.01422.2006
Murphy RM, Lamb GD (2009) Calpain-3 is activated following eccentric exercise. J Appl Physiol (1985) 106:2068. doi:10.1152/japplphysiol.00239.2009, author reply 2069
Murphy RM, Verburg E, Lamb GD (2006) Ca2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle. J Physiol 576:595–612. doi:10.1113/jphysiol.2006.114090
Nicolas G, Fournier CM, Galand C, Malbert-Colas L, Bournier O, Kroviarski Y, Bourgeois M, Camonis JH, Dhermy D, Grandchamp B, Lecomte MC (2002) Tyrosine phosphorylation regulates alpha II spectrin cleavage by calpain. Mol Cell Biol 22:3527–3536
Noma H, Kato T, Fujita H, Kitagawa M, Yamano T, Kitagawa S (2009) Calpain inhibition induces activation of the distinct signalling pathways and cell migration in human monocytes. Immunology 128:e487–e496. doi:10.1111/j.1365-2567.2008.03012.x
Ojima K, Ono Y, Ottenheijm C, Hata S, Suzuki H, Granzier H, Sorimachi H (2011) Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles. J Mol Biol 407:439–449. doi:10.1016/j.jmb.2011.01.057
Pannaccione A, Secondo A, Molinaro P, D'Avanzo C, Cantile M, Esposito A, Boscia F, Scorziello A, Sirabella R, Sokolow S, Herchuelz A, Di Renzo G, Annunziato L (2012) A new concept: Abeta1-42 generates a hyperfunctional proteolytic NCX3 fragment that delays caspase-12 activation and neuronal death. J Neurosci : Off J Soc Neurosci 32:10609–10617. doi:10.1523/JNEUROSCI.6429-11.2012
Quednau BD, Nicoll DA, Philipson KD (1997) Tissue specificity and alternative splicing of the Na+/Ca2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. Am J Physiol 272:C1250–C1261
Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C et al (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81:27–40
Richard I, Roudaut C, Saenz A, Pogue R, Grimbergen JE, Anderson LV, Beley C, Cobo AM, de Diego C, Eymard B, Gallano P, Ginjaar HB, Lasa A, Pollitt C, Topaloglu H, Urtizberea JA, de Visser M, van der Kooi A, Bushby K, Bakker E, Lopez de Munain A, Fardeau M, Beckmann JS (1999) Calpainopathy—a survey of mutations and polymorphisms. Am J Hum Genet 64:1524–1540. doi:10.1086/302426
Sacchetto R, Margreth A, Pelosi M, Carafoli E (1996) Colocalization of the dihydropyridine receptor, the plasma-membrane calcium ATPase isoform 1 and the sodium/calcium exchanger to the junctional-membrane domain of transverse tubules of rabbit skeletal muscle. Eur J Biochem 237:483–488
Sandoval A, Oviedo N, Tadmouri A, Avila T, De Waard M, Felix R (2006) Two PEST-like motifs regulate Ca2+/calpain-mediated cleavage of the CaVbeta3 subunit and provide important determinants for neuronal Ca2+ channel activity. Eur J Neurosci 23:2311–2320. doi:10.1111/j.1460-9568.2006.04749.x
Secondo A, Staiano RI, Scorziello A, Sirabella R, Boscia F, Adornetto A, Valsecchi V, Molinaro P, Canzoniero LM, Di Renzo G, Annunziato L (2007) BHK cells transfected with NCX3 are more resistant to hypoxia followed by reoxygenation than those transfected with NCX1 and NCX2: possible relationship with mitochondrial membrane potential. Cell Calcium 42:521–535. doi:10.1016/j.ceca.2007.01.006
Shoshan-Barmatz V, Weil S, Meyer H, Varsanyi M, Heilmeyer LM (1994) Endogenous, Ca(2+)-dependent cysteine-protease cleaves specifically the ryanodine receptor/Ca2+ release channel in skeletal muscle. J Membr Biol 142:281–288
Singh RB, Chohan PK, Dhalla NS, Netticadan T (2004) The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart. J Mol Cell Cardiol 37:101–110. doi:10.1016/j.yjmcc.2004.04.009
Sivanandam A, Murthy S, Chinnakannu K, Bai VU, Kim SH, Barrack ER, Menon M, Reddy GP (2011) Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells. J Cell Physiol 226:1889–1896. doi:10.1002/jcp.22516
Sorimachi H, Hata S, Ono Y (2011) Impact of genetic insights into calpain biology. J Biochem 150:23–37. doi:10.1093/jb/mvr070
Sprague CR, Fraley TS, Jang HS, Lal S, Greenwood JA (2008) Phosphoinositide binding to the substrate regulates susceptibility to proteolysis by calpain. J Biol Chem 283:9217–9223. doi:10.1074/jbc.M707436200
Tompa P, Buzder-Lantos P, Tantos A, Farkas A, Szilagyi A, Banoczi Z, Hudecz F, Friedrich P (2004) On the sequential determinants of calpain cleavage. J Biol Chem 279:20775–20785. doi:10.1074/jbc.M313873200
Wanichawan P, Hafver TL, Hodne K, Aronsen JM, Lunde IG, Dalhus B, Lunde M, Kvaloy H, Louch WE, Tonnessen T, Sjaastad I, Sejersted OM, Carlson CR (2014) Molecular basis of calpain cleavage and inactivation of the sodium-calcium exchanger 1 in heart failure. J Biol Chem 289:33984–33998. doi:10.1074/jbc.M114.602581
Whelan JA, Russell NB, Whelan MA (2003) A method for the absolute quantification of cDNA using real-time PCR. J Immunol Methods 278:261–269
Yoshimura N, Kikuchi T, Sasaki T, Kitahara A, Hatanaka M, Murachi T (1983) Two distinct Ca2+ proteases (calpain I and calpain II) purified concurrently by the same method from rat kidney. J Biol Chem 258:8883–8889
Zhang S, Kim TS, Dong Y, Kanazawa S, Kawaguchi M, Gao N, Minato H, Takegami T, Nojima T, Asai K, Miura Y (2012) AT motif binding factor 1 (ATBF1) is highly phosphorylated in embryonic brain and protected from cleavage by calpain-1. Biochem Biophys Res Commun 427:537–541. doi:10.1016/j.bbrc.2012.09.092
Zhao X, Moloughney JG, Zhang S, Komazaki S, Weisleder N (2012) Orai1 mediates exacerbated Ca(2+) entry in dystrophic skeletal muscle. PLoS One 7, e49862. doi:10.1371/journal.pone.0049862
Acknowledgments
This research was supported by an equipment grant of The Netherlands Organization for Scientific Research (NWO, No. 911-02-008) and the Centre for Systems Biology Research (CSBR) initiative from the NWO (No. CSBR09/013V).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Michel, L.Y.M., Hoenderop, J.G.J. & Bindels, R.J.M. Calpain-3-mediated regulation of the Na+-Ca2+ exchanger isoform 3. Pflugers Arch - Eur J Physiol 468, 243–255 (2016). https://doi.org/10.1007/s00424-015-1747-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-015-1747-8